Clinical Trials Directory

Trials / Sponsors / Lanzhou Institute of Biological Products Co., Ltd

Lanzhou Institute of Biological Products Co., Ltd

Industry · 7 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody
Rabies (Healthy Volunteers)
Phase 22026-01-31
Enrolling By InvitationClinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Hum
Tetanus
Phase 12025-08-18
UnknownPhase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL
Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
Phase 12021-12-20
UnknownA Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB
Overactive Bladder
Phase 32016-03-01
UnknownA Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vacc
Meningococcal Meningitis
Phase 12015-06-01
UnknownA Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic Migrain
Chronic Migraine
Phase 32014-09-01
CompletedA Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb
Cerebrovascular Accident
Phase 32014-07-01